CytoReason, an Israeli company using AI for disease models, raised $80 million in funding with investors like Nvidia and Pfizer. The company plans to expand its models, data, and open an office in Cambridge, MA.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing